Structure of the complex between dock9 and cdc42. Deposition Author(s): Barford, D. , Roe, S.M. , Yang, J.
Date: 2009-07-02 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Homo Sapiens Sequences Data: 2WMO_A , 2WMO_B
Structure of the n-terminal brct domain of human microcephalin (mcph1) Deposition Author(s): Bayliss, R. , Richards, M.W. , Roe, S.M.
Date: 2009-09-14 Method: X-RAY DIFFRACTION Resolution: 1.6 Å Organism(s): Homo Sapiens Sequences Data: 2WT8_A , 2WT8_B , 2WT8_C , 2WT8_D
Hsp90 complexed with a resorcylic acid macrolactone. Deposition Author(s): Moody, C.J. , Pearl, L.H. , Prodromou, C. , Roe, S.M.
Date: 2010-04-29 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Saccharomyces Cerevisiae Sequences Data: 2XD6_A
Macrolactone inhibitor bound to hsp90 n-term Deposition Author(s): Moody, C.J. , Pearl, L.H. , Prodromou, C. , Roe, S.M.
Date: 2010-11-08 Method: X-RAY DIFFRACTION Resolution: 1.85 Å Organism(s): Saccharomyces Cerevisiae Sequences Data: 2XX2_A , 2XX2_B , 2XX2_C , 2XX2_D
Macrolactone inhibitor bound to hsp90 n-term Deposition Author(s): Moody, C.J. , Pearl, L.H. , Prodromou, C. , Roe, S.M.
Date: 2010-11-08 Method: X-RAY DIFFRACTION Resolution: 2.199 Å Organism(s): Saccharomyces Cerevisiae Sequences Data: 2XX4_A
Macrolactone inhibitor bound to hsp90 n-term Deposition Author(s): Moody, C.J. , Pearl, L.H. , Prodromou, C. , Roe, S.M.
Date: 2010-11-08 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Saccharomyces Cerevisiae Sequences Data: 2XX5_A
E88g-n92l mutant of n-term hsp90 complexed with geldanamycin Deposition Author(s): Pearl, L.H. , Prodromou, C. , Roe, S.M.
Date: 2011-04-12 Method: X-RAY DIFFRACTION Resolution: 2.37 Å Organism(s): Saccharomyces Cerevisiae Sequences Data: 2YGA_A
Structural characterization of 5-aryl-4-(5-substituted-2-4- dihydroxyphenyl)-1,2,3-thiadiazole hsp90 inhibitors. Deposition Author(s): Pearl, L.H. , Prodromou, C. , Roe, S.M.
Date: 2011-05-10 Method: X-RAY DIFFRACTION Resolution: 1.6 Å Organism(s): Homo Sapiens Sequences Data: 2YI0_A
Structural characterization of 5-aryl-4-(5-substituted-2-4- dihydroxyphenyl)-1,2,3-thiadiazole hsp90 inhibitors. Deposition Author(s): Pearl, L.H. , Prodromou, C. , Roe, S.M.
Date: 2011-05-10 Method: X-RAY DIFFRACTION Resolution: 2.5 Å Organism(s): Homo Sapiens Sequences Data: 2YI5_A
Structural characterization of 5-aryl-4-(5-substituted-2-4- dihydroxyphenyl)-1,2,3-thiadiazole hsp90 inhibitors. Deposition Author(s): Pearl, L.H. , Prodromou, C. , Roe, S.M.
Date: 2011-05-10 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Homo Sapiens Sequences Data: 2YI6_A